Cyclacel to present at the oppenheimer 31st annual healthcare conference

Berkeley heights, n.j., march 15, 2021 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the company will present at the oppenheimer 31st annual healthcare conference, a virtual event, on thursday, march 18, 2021 at 9:20 am (edt). spiro rombotis, president & chief executive officer, will provide an overview of the company and progress in key programs. cyclacel will host one-on-one meetings with investors during the event.
CYCC Ratings Summary
CYCC Quant Ranking